Latest News about BMY
Recent news which mentions BMY
LianBio Touts Positive Data From Bristol Myers-Partnered Heart Drug In Chinese Patients
April 26, 2023
From Benzinga
From Benzinga
Bristol-Myers Squibb Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 25, 2023
Tickers
BMY
From Benzinga
From Motley Fool
From Motley Fool
Is Aurinia Pharmaceuticals Up for Grabs? Shareholder Suggests a Quick Sale for a Bigger Payday
April 24, 2023
From Benzinga
From Motley Fool
Thinking Of Buying Healthpeak Properties? Here Are The Properties And Tenants You'd Be Adding To Your Portfolio
April 21, 2023
From Benzinga
Why Shares of Legend Biotech Jumped Wednesday
April 19, 2023
From Motley Fool
Evaxion Biotech Says Personalized Cancer Immunotherapy Meets Primary Endpoint In Melanoma Patients
April 18, 2023
From Benzinga
Merck’s $10.8 billion takeover of Prometheus is a good strategic move that gives it a foothold in immunology
April 17, 2023
From MarketWatch
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
April 16, 2023
From InvestorPlace
From Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
April 11, 2023
From Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
April 11, 2023
From Benzinga
2 Top Stocks to Buy in April and Hold Forever
April 08, 2023
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
April 07, 2023
From Benzinga
2 Ultra-Cheap Dividend Stocks to Buy in April
April 04, 2023
From Motley Fool
Bristol Myers' Flagship Opdivo Shows Long Term Durable Benefits In Lung Cancer Patients
March 30, 2023
Tickers
BMY
From Benzinga
From Benzinga
AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners
March 28, 2023
From Benzinga
From Motley Fool
From Motley Fool
From Benzinga
Takeda's Highest Dose Psoriasis Candidate Can Potentially Beat Bristol Myers' Approved Drug, Analyst Says
March 20, 2023
From Benzinga
Wall Street Is Bullish on GE HealthCare as It Invests in AI
March 20, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
